Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198

Related Articles by Review for PubMed (Select 17928349)

1.

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE Jr.

J Virol. 2007 Dec;81(24):13710-22. Epub 2007 Oct 10.

3.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
4.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
5.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS.

Viral Immunol. 2005;18(2):255-66. Review.

PMID:
16035938
7.

Mucosal vaccines against respiratory syncytial virus.

Yang K, Varga SM.

Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Review.

8.

Alphavirus replicon particles as candidate HIV vaccines.

Davis NL, West A, Reap E, MacDonald G, Collier M, Dryga S, Maughan M, Connell M, Walker C, McGrath K, Cecil C, Ping LH, Frelinger J, Olmsted R, Keith P, Swanstrom R, Williamson C, Johnson P, Montefiori D, Johnston RE.

IUBMB Life. 2002 Apr-May;53(4-5):209-11. Review.

PMID:
12120997
9.

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

González PA, Bueno SM, Riedel CA, Kalergis AM.

Curr Med Chem. 2009;16(34):4609-25. Review.

PMID:
19903147
10.

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Collins PL, Melero JA.

Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Review.

11.

Respiratory syncytial virus infections: old challenges and new opportunities.

Mejías A, Chávez-Bueno S, Jafri HS, Ramilo O.

Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S189-96, discussion S196-7. Review.

PMID:
16378045
12.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
13.

Prevention strategies for respiratory syncytial virus: passive and active immunization.

Englund JA.

J Pediatr. 1999 Aug;135(2 Pt 2):38-44. Review.

PMID:
10431138
14.
15.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

16.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
17.

Respiratory syncytial virus: the virus, the disease and the immune response.

Ogra PL.

Paediatr Respir Rev. 2004;5 Suppl A:S119-26. Review.

PMID:
14980256
18.

Structure and function of respiratory syncytial virus surface glycoproteins.

McLellan JS, Ray WC, Peeples ME.

Curr Top Microbiol Immunol. 2013;372:83-104. doi: 10.1007/978-3-642-38919-1_4. Review.

19.

Immunization strategies for the prevention of pneumovirus infections.

Bennett N, Ellis J, Bonville C, Rosenberg H, Domachowske J.

Expert Rev Vaccines. 2007 Apr;6(2):169-82. Review.

PMID:
17408367
20.

Respiratory syncytial virus infection in adults.

Falsey AR.

Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. Review.

PMID:
17458771
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk